A rating of 79 puts China Pharma Holdings, Inc. (CPHI) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. China Pharma Holdings, Inc.'s score of 79 means it scores higher than 79% of stocks in the industry. China Pharma Holdings, Inc. also received an overall rating of 48, putting it above 48% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 127 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With China Pharma Holdings, Inc. Stock Today?
China Pharma Holdings, Inc. (CPHI) stock is lower by -3.6% while the S&P 500 is higher by 0.74% as of 11:49 AM on Tuesday, Jun 30. CPHI is lower by -$0.02 from the previous closing price of $0.69 on volume of 2,105,021 shares. Over the past year the S&P 500 is higher by 3.76% while CPHI is higher by 120.00%. CPHI lost -$0.48 per share the over the last 12 months.
